Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon‐γ release assay vs. tuberculin skin test

No abstract is available for this paper.

• Publication year

  2009

• Venue

  British Journal of Dermatology

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2133.2009.09331.xPMID 19659473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNFalpha blockade in human diseases: an overview of efficacy and safety.

  2008cited by this paper
• Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies

  2008cited by this paper
• National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.

  2008cited by this paper
• QuantiFERON®‐TB Gold testing for tuberculosis in psoriasis patients commencing anti‐tumour necrosis factor α therapy

  2008cited by this paper
• TNFα blockade in human diseases : An overview of efficacy and safety

  2008cited by this paper
• Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchMenzies D, Pai M, Comstock G (McGill Univ, Montreal; Johns Hopkins Univ, Baltimore, Md) Ann Intern Med 146:340–354, 2007§

  2008cited by this paper
• Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.

  2007cited by this paper
• Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy.

  2007cited by this paper
• Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.

  2006cited by this paper
• Tuberculosis. Clinical diagnosis and management of tuberculosis and measures for its prevention and control

  2006cited by this paper
• BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment

  2005cited by this paper
• Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

  2005cited by this paper
• BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment.

  2005cited by this paper
• Tuberculosis and opportunistic infections: relevance to biologic agents.

  2004cited by this paper
• Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.

  2003cited by this paper

• Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years' Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country.

  2025cites this paper
• Tuberculosis infection in rheumatological patients receiving tumor necrosis factor – alpha inhibitors

  2025cites this paper
• Comparison of PPD and IGST Sensitivity in Latent Tuberculosis Assessment (Cross-sectional Study)

  2025cites this paper
• New‐onset extrapulmonary tuberculosis in negative latent tuberculosis infection screening patients with Crohn's disease under anti‐TNF therapy in a tuberculosis‐endemic region: A case series

  2023cites this paper
• Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report

  2023cites this paper
• Interferon (cid:2) Assays in the Diagnosis of Tuberculosis Infection in Psoriasis Patients Who Are Candidates for Biologic Therapies (cid:2) Interferon (cid:2) Assays in the Diagnosis of Tuberculosis in Psoriasis Patients

  2022cites this paper
• Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment

  2021cites this paper
• The reliability of tuberculin skin test in the diagnosis of latent tuberculosis infection in psoriasis patients: A case‐control study

  2020cites this paper
• Infliximab, Golimumab, and Certolizumab Pegol

  2020cites this paper
• Immune checkpoint inhibitors and tuberculosis: an old disease in a new context.

  2020cites this paper
• Active Tuberculosis in Patients with Psoriasis Receiving Biologic Therapy: A Systematic Review

  2019cites this paper
• Tuberculosis Screening in Patients with Psoriasis Receiving Biologic Therapy: A Retrospective Cohort Study.

  2018cites this paper
• Risk of infection associated with anti-TNF-α therapy

  2018cites this paper
• Management of long‐term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting

  2017cites this paper
• Interferon Assays in the Diagnosis of Tuberculosis Infection in Psoriasis Patients Who Are Candidates for Biologic Therapies

  2017cites this paper
• Association of clinical properties and compatibility of the QuantiFERON‐TB Gold In‐Tube test with the tuberculin skin test in patients with psoriasis

  2016cites this paper
• Latent tuberculosis diagnostic tests to predict longitudinal tuberculosis during dialysis: a meta-analysis.

  2016cites this paper
• Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection.

  2016cites this paper
• Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Biologic Agents and Tuberculosis

  2016cites this paper
• Assessment and monitoring of biologic drug adverse events in patients with psoriasis

  2016cites this paper
• Higher Performance of QuantiFERON TB Compared to Tuberculin Skin Test in Latent Tuberculosis Infection Prospective Diagnosis

  2016cites this paper
• Estimation of the prevalence of latent tuberculosis infection in patients with moderate to severe plaque psoriasis in Spain: The Latent study.

  2015cites this paper
• Screening Strategies for the Identification of Latent Tuberculosis

  2015cites this paper
• Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida

  2015cites this paper
• Estimation of the prevalence of latent tuberculosis infection in patients with moderate to severe plaque psoriasis in Spain: The Latent study.

  2015cites this paper
• Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis

  2015cites this paper
• Diagnosis and Management of Latent Tuberculosis Infection.

  2015cites this paper
• To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis.

  2015cites this paper
• The risk of tuberculosis in patients with psoriasis treated with anti‐tumor necrosis factor agents

  2015cites this paper
• Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study.

  2015cites this paper
• Revista4Vol89ingles-_Layout 1

  2014cites this paper
• Adverse effects of golimumab in the treatment of rheumatologic diseases

  2014cites this paper
• Cutaneous tuberculosis: diagnosis, histopathology and treatment - Part II*

  2014cites this paper
• Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening

  2014cites this paper
• Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis factor-alfa antagonists.

  2014cites this paper
• Latent tuberculosis infection in psoriasis and other dermatological immunomediated diseases: a combined approach by QuantiFERON®‐TB Gold and tuberculin skin tests

  2014cites this paper
• Diagnostic Accuracy of Chest Radiography for the Diagnosis of Tuberculosis (TB) and Its Role in the Detection of Latent TB Infection: a Systematic Review

  2014cites this paper
• Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious?

  2014cites this paper
• Infliximab and Golimumab

  2014cites this paper
• Dermoscopy of an osteonevus of Nanta

  2014cites this paper
• NEW ADVANCES IN DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION: A REVIEW ARTICLE

  2014cites this paper
• Mycobacterium Tuberculosis in New Biologic Era

  2014cites this paper
• Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis.

  2014cites this paper
• Avaliação da resposta imune anti-Mycobacterium tuberculosis em pacientes com psoríase moderada a grave submetidos à terapia com inibidor de fator de necrose tumoral, infliximabe

  2014cites this paper
• Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.

  2014cites this paper
• Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers

  2014cites this paper
• Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis factor-alfa antagonists.

  2014cites this paper
• Risk of tuberculosis with the use of anti-TNF medications in psoriasis: incidence, screening and management.

  2014cites this paper
• Screening for Latent TB Infection in a Psoriasis Patient with History of BCG Vaccination and Exposure to TB Prior to Treatment with an Anti-TNF-α Agent

  2013cites this paper
• Interferon‐γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis

  2013cites this paper
• Interferon-γ release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review.

  2013cites this paper
• Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence

  2013cites this paper
• Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy

  2013cites this paper
• IFN-γ release assay for tuberculosis in psoriasis patients treated with TNF antagonists : in vivo and in vitro analysis

  2013cites this paper
• Mycobacterial Interferon-γ Release Variations During Longterm Treatment with Tumor Necrosis Factor Blockers: Lack of Correlation with Clinical Outcome

  2013cites this paper
• Diagnosis and treatment of latent infection with Mycobacterium tuberculosis

  2013cites this paper
• Evaluating the use of the interferon‐γ response to Mycobacterium tuberculosis‐specific antigens in patients with psoriasis prior to antitumour necrosis factor‐α therapy: a prospective head‐to‐head cross‐sectional study

  2013cites this paper
• IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.

  2013cites this paper
• Biologic therapy and tuberculosis: our experience and review of literature

  2013cites this paper
• Nuevas técnicas in vitro en el diagnóstico de la infección tuberculosa

  2013cites this paper
• Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate–severe psoriasis in Spain. BIOBADADERM registry

  2013cites this paper
• T-cell-based IFN-γ release assays for the diagnosis of latent tuberculosis infection: have they met our expectations?

  2013cites this paper
• Positive Tuberculin Skin Test or Interferon-Gamma Release Assay in Patients with Radiographic Lesion Suggesting Old Healed Tuberculosis

  2012cites this paper
• Reactivation of Tuberculosis in Three Cases of Psoriasis after Initiation of Anti-TNF Therapy

  2012cites this paper
• Técnicas basadas en la detección de IFN-γ en el diagnóstico de la infección tuberculosa en pacientes con psoriasis candidatos a terapias biológicas

  2012cites this paper
• Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting.

  2012cites this paper
• Psoriatic Disease and Tuberculosis Nowadays

  2012cites this paper
• Drugs that act on the immune system: cytokines and monoclonal antibodies

  2012cites this paper
• Psoriasis: an evidence‐based update. Report of the 9th Evidenced Based Update Meeting, 12 May 2011, Loughborough, U.K.

  2012cites this paper
• Comparação de um teste Igra (Interferon Gamma Release Assay) com o teste Tuberculínico no diagnóstico da infeção latente por M. Tuberculosis em doentes com Psoríase

  2012cites this paper
• Leprosy and the natural selection for psoriasis.

  2012cites this paper
• Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases

  2012cites this paper
• Clinical applicability of Quantiferon‐TB‐Gold testing in psoriasis patients during long‐term anti‐TNF‐alpha treatment: a prospective, observational study

  2011cites this paper
• Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting.

  2011cites this paper
• Comparison of Two Gamma Interferon Release Assays and Tuberculin Skin Testing for Tuberculosis Screening in a Cohort of Patients with Rheumatic Diseases Starting Anti-Tumor Necrosis Factor Therapy

  2011cites this paper
• Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety.

  2011cites this paper
• Place des tests à l’interféron (IGRAs) dans le dépistage de la tuberculose latente (TBL) avant prescription d’agents anti-TNF : le point

  2011cites this paper
• Advances in the treatment of moderate-to-severe plaque psoriasis.

  2011cites this paper
• Clinical experience of QuantiFERON®‐TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan

  2011cites this paper
• Drugs that act on the immune system

  2011cites this paper
• Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders

  2011cites this paper
• Tuberculose pleural após uso de adalimumabe na doença de Crohn: relato de caso

  2011cites this paper
• Incidence of tuberculosis infection in psoriatic patients on anti‐TNF therapy: report of a case series with 144 patients

  2011cites this paper
• Psoríase eritrodérmica com regressão após profilaxia com isoniazida e terapia antidepressiva: relato de caso

  2011cites this paper
• Challenges in Diagnosing Latent Tuberculosis Infection in Patients Treated with Tumor Necrosis Factor Antagonists

  2011cites this paper
• Erythrodermic psoriasis with regression after prophylaxis with isoniazid and antidepressant therapy: case report.

  2011cites this paper
• T-SPOT.TB assay usage in adults and children

  2011cites this paper
• The risk of tuberculosis in patients treated with TNF antagonists

  2011cites this paper
• Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach

  2011cites this paper
• Tuberculosis screening before biologic therapy. Comment about the article entitled "role for interferon-gamma release assays in latent tuberculosis screening before TNF-α antagonist therapy" by Liote H et al.

  2011cites this paper
• Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid

  2011cites this paper
• Cutaneous lupus erythematosus : Update of therapeutic options Part II

  2011cites this paper
• Cutaneous lupus erythematosus: update of therapeutic options part II.

  2011cites this paper
• Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor‐α treatment: every new solution breeds new doubts

  2011cites this paper
• Role for interferon-gamma release assays in latent tuberculosis screening before TNF-α antagonist therapy.

  2011cites this paper
• Cutaneous lupus erythematosus: update of therapeutic options part I.

  2011cites this paper
• A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy

  2011influential citation
• Interferon-&ggr; release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

  2010cites this paper